Source: PRWeb

Press Release: Seraphina : Seraphina Therapeutics' Groundbreaking Discovery of C15:0 as a Leading Longevity Nutrient Recognized as a 2024 Fast Company's World Changing Idea

Eighth Annual Awards Honors New and Inspiring Solutions to the Most Daunting Challenges of Today SAN DIEGO, May 15, 2024 /PRNewswire-PRWeb/ -- Seraphina Therapeutics is proud to announce its recognition as a 2024 World Changing Idea in Fast Company's Wellness Category. This award honors...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Eric Venn-Watson's photo - Co-Founder of Seraphina

Co-Founder

Eric Venn-Watson

CEO Approval Rating

90/100

Read more